OrthoGrid Systems and nView medical Partnering Annnounce Partnership

Section 2

Northwell Health Sends Vaccinators to Ecuador

At the request of Ecuador’s Minster of Health, and for the first time since the start of the pandemic, the Northwell Health CGH team traveled outside of the U.S. on June 13 to help get shots in arms relieve overburdened health care workers in the South American country who have been working around the clock in the race to vaccinate their population.

Fusion Marketplace Changes Healthcare Traveler Experience

Fusion Marketplace is a traveler-first driven platform giving healthcare professionals the power to make decisions in their careers that they haven't been able to in the past.

Announced today, nView medical, a leading innovator in 3D medical imaging, and OrthoGrid Systems, a global MedTech leader offering intraoperative alignment technologies, are partnering to provide integrated solutions that increase surgical accuracy and OR efficiency and improve patient outcomes.

As the first step for implementation, the companies are executing a proof of concept for a periacetabular osteotomy (PAO) procedure, and, after completion, will expand to additional musculoskeletal procedures. PAO surgery aims to preserve the hip joint by repositioning the native acetabulum, a complex pediatric joint preservation surgery that aims to reduce or eliminate the risk of a future total hip replacement. OrthoGrid offers the first PAO-specific, imaging-based, surgical navigation application on the market.

“Many problems in orthopedic surgery are 3D problems. Currently, they are solved based on 2D imaging data,” says Dr. Chris Peters, Professor of Orthopaedics at the University of Utah and a renowned hip preservation specialist. “Being able to merge OrthoGrid’s Hip Preservation application with nView’s real-time, 3D, intraoperative imaging data would bring new and valuable information during critical surgical steps, such as the acetabular osteotomy and positioning.”

Both nView medical and OrthoGrid technologies are AI-driven, open platforms designed to work within the surgical theater to improve accuracy, workflow efficiency, and patient outcomes. With the nView 3D imaging data, planning can be achieved intraoperatively, reducing the need for preoperative planning. Similarly, postoperative alignment verification via x-rays may be avoided, and overall radiation exposure to young patients is expected to reduce drastically.

“We are thrilled to engage in this partnership with OrthoGrid, as we truly have aligned company missions: To enhance surgeons’ experience in the OR while simultaneously working to improve patient outcomes,” said Cristian Atria, Founder and CEO at nView Medical. “OrthoGrid’s expert knowledge of procedural steps and intraoperative problem-solving, along with their commitment to AI-driven, imaging-based automation, is an intuitive next step to further expand the opportunity behind real-time, 3D images. We look forward to seeing the immense impact combining these two innovations will have on musculoskeletal procedures in the years to come.”

“This partnership combines two technological needs within intraoperative imaging: Real-time, 3D imaging, and procedural decision making into one unique solution,” said Edouard Saget, Co-Founder, and Co-CEO at OrthoGrid Systems. “We seek to optimize the value equation in orthopedics, one of OrthoGrid’s long-term commitments. By integrating our applications within nView’s 3D imaging system, we are consolidating the number of devices required in the operating room, thus improving operating room efficiency, staff training, and the overall value proposition to the hospital. At the end of the day, we’re always working to make surgeons’ experience in the OR as seamless as possible.”



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles